225Ac-PSMA-R2 clinical trials

Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT

This study looked at a new drug, 225Ac-PSMA-R2, for men with advanced prostate cancer. Researchers wanted to see if it was safe and if it helped fight the cancer. The study has finished enrolling patients.